Press release
Berlin´s Medical-Technical Companies: Permanent Secretary Almuth Hartwig-Tiedt visits Berlin Heart.
Almuth Hartwig-Tiedt (third from the right) together with Berlin Heart General Management.
Together with the General Management of Berlin Heart, latest therapy options with heart-assist devices were discussed. As Berlin Heart´s EXCOR® Pediatric device for children is unique worldwide, this obviously was her main interest. It is specially designed to meet the needs and requirements of newly born and infants. Other topics discussed were the company´s history and the decision for Berlin as the company´s headquarters. Here, the General Management pointed out the close location to the German Heart Institute, Berlin – a world-wide leading center which was significantly involved in the development of the EXCOR® system and with whom close cooperation has existed for many years. Moreover Dr. Stefan Thamasett, one of the General Managers of Berlin Heart, reiterated the excellent infrastructure of Berlin which is pivotal for an internationally active undertaking: „On the one hand, our devices need to be shipped worldwide at very short notice, and on the other hand, we benefit from the highly professional research cluster of Berlin such as Campus WISTA in Berlin Adlershof, who are reliable partners in the development of our products.
Almuth Hartwig-Tiedt, who sees the company as an important part of the Berlin-Brandenburg health cluster, was also informed of the current supplier situation in terms of the special requirements of a Med-Tech company. In addition, the latest research and development activities were discussed. The plans to produce an even smaller and fully implantable heart-assist device in the future, seemed to impressed her.
At the conclusion of her company tour, Frau Hartwig-Tiedt stated: „Amazing what kind of therapeutic solutions are available for patients suffering from heart failure. If one gains additional detailed insight by seeing the complex production process, it is easier to comprehend the importance of these systems“, so ended the successful visit of the Permanent Secretary for Economics, Technology and Women’s Issues to Berlin Heart headquarters.
About Berlin Heart
Berlin Heart GmbH is the only company worldwide that develops, produces, and distributes implantable and external ventricular assist devices for patients of every age and body size. The devices INCOR®, EXCOR® Adult and EXCOR® Pediatric can support failing hearts short-, mid- and long-term and therefore offer a life-saving therapy. Customers moreover benefit from clinical and technical support by Berlin Heart VAD specialists who are available 7-24. The company is the market leader in Germany and Europe.
About EXCOR®
EXCOR® is a para-corporeal ventricular assist device for patients of all age groups, from newborns to adults. It is used for short-, mid- and long-term cardiac support and can support failing hearts for any duration from a couple of days to several months and years. Since the first implantation in 1988 EXCOR® has been implanted in more than 3.000 patients worldwide.
EXCOR® is currently under clinical investigation for paediatric use in USA. All other products are not FDA approved.
Berlin Heart GmbH
Kerstin Unkel
Marketing & PR
Wiesenweg 10
12247 Berlin
unkel@berlinheart.de
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Berlin´s Medical-Technical Companies: Permanent Secretary Almuth Hartwig-Tiedt visits Berlin Heart. here
News-ID: 191427 • Views: …
More Releases from Berlin Heart
100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed.
The clinics in Spain benefit from an excellent service by Palex Medical…
The 1,500th child supported by the Berlin Heart ventricular assist device has be …
The EXCOR® Pediatric ventricular assist device (VAD) has been implanted in more than 1,500 children worldwide to save their lives.
In June 2014 for the 1,500th time, the EXCOR® Pediatric device was implanted to save the life of a child: a 14-year-old boy from Hong Kong who was suffering from dilated cardiomyopathy since the age of four was supported with the life-saving device. Up to that point the teenager had…
More Releases for EXCOR®
100th EXCOR® Implantation in Spain
In March 2015 the clinic La Paz Madrid recorded a particular success: After ten years of EXCOR® therapy in Spain, the 100th implantation of the Berlin Heart was performed. La Paz is one of the leading Spanish hospitals for pediatric heart surgery. Almost simultaneously in another clinic in Madrid the 101st implantation took place and further implantations followed.
The clinics in Spain benefit from an excellent service by Palex Medical…
1. Japanese EXCOR® Pediatric patient successfully transplanted
Berlin, 19.06.2013: The wait for a donor heart is over for the 1st Japanese patient treated with the EXCOR® Pediatric. On May 20th, 2013 the two-year-old girl was successfully transplanted at Morgan Stanley Childrens Hospital, New York Columbia Presbyterian Medical Center. According to the patient’s physicians, she tolerated the procedure well and is recovering as expected.
In August 2012, for the first time in Japan’s history, it was possible…
Longest support time with the EXCOR® Pediatric ventricular assist device
Six year old Lara from Erlangen is the toddler with the longest support time of a ventricular assist device (VAD) in the world.
The small patient was treated an entire 877 days with the VAD EXCOR® Pediatric in the University Hospital in Erlangen and, thanks to this therapy, could recover so well that she was now able to receive a new heart a few days ago.
In February 2010 Lara was in…
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled.
The study, which enrolled the first patient in November 2007, is the first prospective clinical…
Major Milestone Achieved – EXCOR® Pediatric HDE Application Under Review
Berlin Germany 12 April 2011: The Berlin Heart Group reported today that the results of the US IDE Trial for the Berlin Heart EXCOR® Pediatric Ventricular Assist Device have been submitted to the FDA in an HDE application. The FDA has informed the company that the application is officially under review and that a tentative panel date has been scheduled.
The study, which enrolled the first patient in November 2007,…
Successful transatlantic EXCOR® air ambulance transportations
Berlin, 30 March 2011. Four young children suffering from severe heart failure and consequently supported by the EXCOR® ventricular assist device, were safely and successfully transported by aircraft during the last months.
The so-called artificial heart was implanted in order to assist the patient’s heart function of pumping blood through the body. As a life-saving device, it bridges the time until a donor heart is found and transplantation becomes possible.…
